26 August 2026 - Annovis Bio Inc (NYSE:ANVS), a Phase 3 clinical-stage biotechnology company developing an investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer�...
M2 Pharma
Original source
next uk
Check live status on DownRightNow


